Clinical Frailty Assessment and Postoperative Adverse Outcomes and Quality of Life in Elderly Patients

NCT05387850 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12000

Last updated 2024-06-10

No results posted yet for this study

Summary

The frailty index may represent a useful decision support tool to optimize modifiable drivers of the quality and cost of digestive surgery care. However, classical indices are cumbersome to compute and often require unavailable data. The number of operations in the elderly is gradually increasing, and the prevention and treatment of adverse postoperative outcomes has become the focus of clinical attention. More recently, clinicians have focused more on the association between frailty and adverse postoperative outcomes, but this has not been rigorously applied to long-term prospective studies in older patients.

Conditions

  • Perioperative Complications

Interventions

OTHER

no intervention

no intervention

Sponsors & Collaborators

  • Beijing Tiantan Hospital

    collaborator OTHER
  • Peking University First Hospital

    collaborator OTHER
  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    collaborator OTHER
  • Xiangya Hospital of Central South University

    collaborator OTHER
  • Beijing Anzhen Hospital

    collaborator OTHER
  • Central South University

    collaborator OTHER
  • Peking University People's Hospital

    collaborator OTHER
  • Zhejiang University

    collaborator OTHER
  • Fudan University

    collaborator OTHER
  • Sun Yat-sen University

    collaborator OTHER
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER
  • China-Japan Friendship Hospital

    collaborator OTHER
  • The Affiliated Hospital Of Guizhou Medical University

    collaborator OTHER
  • First Affiliated Hospital of Xinjiang Medical University

    collaborator OTHER
  • First Affiliated Hospital of Guangxi Medical University

    collaborator OTHER
  • Taihe Hospital

    collaborator OTHER
  • Zhejiang Provincial People's Hospital

    collaborator OTHER
  • Shanghai Zhongshan Hospital

    collaborator OTHER
  • Chinese PLA General Hospital

    lead OTHER

Principal Investigators

  • Mi Weidong, PhD · Chinese PLA hospital

Eligibility

Min Age
65 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-20
Primary Completion
2021-10-30
Completion
2022-01-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05387850 on ClinicalTrials.gov